p53/p16-Independent Epigenetic Therapy With Oral Decitabine/Tetrahydrouridine for Pancreatic Cancer
Clinical trial NCT02847000 · COMPLETED
Trial details
- NCT number
- NCT02847000
- Sponsor
- Yogen Saunthararajah
- Status
- COMPLETED
- Phase
- Early Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2016-12-20
- Primary completion
- 2017-10-25
- Enrollment
- 13
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.